Evaluation of vitamin B12 and folate status in the nursing home

Journal of the American Medical Directors Association

Volumn 2, Issue 5, 2001, Pages 230-238

  Smith, Rick L ^a  

^a Los Angeles Jewish Home for the Aging   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLMALONIC ACID; PYRIDOXINE;

AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL LABORATORY; COGNITIVE DEFECT; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; FOLIC ACID DEFICIENCY; HEALTH STATUS; HUMAN; HUMAN TISSUE; MEGALOCYTOSIS; NEUROLOGIC DISEASE; NURSING HOME; RISK FACTOR;

EID: 0034821978     PISSN: 15258610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-8610(04)70210-8     Document Type: Article

References (78)

1. Neurologic and evoked potential abnormalities in subtle cobalamin deficiency states, including deficiency without anemia and with normal absorption of free cobalamin
2. Subtle and atypical cobalamin deficiency states
3. High prevalence of cobalamin deficiency in elderly outpatients
4. The significance of subnormal serum vitamin B12 concentration in older people: A case control study
5. Vitamin B12 deficiency in older people: Improving diagnosis and preventing disability
6. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities
7. Vitamin B-12 deficiency in the elderly: Current dilemmas
8. Cobalamin and osteoblast-specific proteins
9. Risk of fractures in patients with pernicious anemia
10. Staging vitamin B-12 (cobalamin) status in vegetarians
11. Impaired antibody responses to pneumococcal polysaccharide in elderly patients with low serum vitamin B12 levels
12. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study
13. Nutritionally independent B12 deficiency and Alzheimer Disease
14. Homocysteine and neurologic disease
15. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease
16. The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population
17. Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment
18. Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects
19. Low serum cobalamin in a nursing home: A clinical experience
20. Neurologic aspects of cobalamin deficiency
21. Shaky-leg syndrome and vitamin B12 deficiency
22. Prevalence of undiagnosed pernicious anemia in the elderly
23. Cobalamin, the stomach, and aging
24. Normalization of low vitamin B12 serum levels in older people by oral treatment
25. Free and protein-bound cobalamin absorption in healthy middle-aged and older subjects
26. The aging process as a modifier of metabolism
27. Current concepts in cobalamin deficiency
28. Mild cobalamin deficiency in older Dutch subjects
29. Low serum B12 levels in a hematologically normal elderly subpopulation
30. Use of the deoxyuridine suppression test to evaluate vitamin B12 and folate status
31. Cobalamin deficiency in the elderly
32. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
33. Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine
34. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations
35. Comparison of the deoxyuridine suppression test with serum levels of methylmalonic acid and homocysteine in mild cobalamin deficiency
36. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation
37. Laboratory diagnosis of vitamin B12 and folate deficiency: A guide for the primary care physician
38. Evaluation of indicators of cobalamin deficiency defined as cobalamin-induced reduction in increased serum methylmalonic acid
39. Screening for vitamin B12 deficiency: Caveat emptor
40. Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: Ethnic and sex differences in cobalamin and metabolite abnormalities
41. Racial differences in prevalence of cobalamin and folate deficiencies in disabled elderly women
42. Vitamin B12 deficiency
43. Failure of assay to identify low cobalamin concentrations
44. Metabolite assay in cobalamin and folate deficiency
45. Cobalamin and folate evaluation: Measurement of methylmalonic acid and homocysteine vs vitamin B12 and folate
46. Prevalence of cobalamin deficiency in the Framingham elderly population
47. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people
48. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies
49. Clinical spectrum and diagnosis of cobalamin deficiency
50. Screening elderly populations for cobalamin (vitamin B12) deficiency using the urinary methylmalonic assay by gas chromatography mass spectrometry
51. Diagnosis of cobalamin deficiency I: Usefulness of serum methylmalonic acid and total homocysteine concentrations
52. Screening the older population for cobalamin (vitamin B12) deficiency
53. Oral cobalamin for pernicious anemia: Medicine's best kept secret?
54. Oral cobalamin for treatment of pernicious anemia?
55. Oral therapy for cobalamin deficiency
56. Dietary intake of cobalamin in elderly people who have abnormal serum cobalamin, methylmalonic acid and homocysteine levels
57. Pernicious anemia
58. Risk for colorectal adenocarcinoma in pernicious anemia: A population-based cohort study
59. Folic acid.: An update, with new recommended daily allowances
60. Homocysteine, folate, vitamin B-12, and vitamin B-6 in patients receiving antiepileptic drug monotherapy
61. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14μmol/L
62. The controversy over homocysteine and cardiovascular risk
63. Homocysteine and cardiovascular disease: Cause or effect?
64. Plasma homocyst(e)ine levels and folic acid supplementation
65. The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations
66. Homocysteine and cysteine: Determinants of plasma levels in middle-aged and elderly subjects
67. Folate status of elderly women following moderate folate depletion responds only to a higher folate intake
68. Multivitamin/Mineral supplementation improves plasma B-vitamin status and homocysteine concentration in healthy older adults consuming a folate-fortified diet
69. Results of an international round robin for serum and whole-blood folate
70. Homocysteine, hypothyroidism, and the effect of thyroid hormone replacement
71. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism
72. Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women
73. The effect of a subnormal vitamin B-6 status on homocysteine metabolism
74. Plasma pyridoxal 5′[prime]-phosphate concentration and dietary vitamin B-6 intake in free-living, low-income elderly people
75. Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin supplementation in free-living elderly people
76. Vitamin B-6 malnutrition among elderly Europeans: The SENECA study
77. Metabolic markers of vitamin nutritional status
78. Folate status worsens in recently institutionalized elderly people without evidence of functional deterioration